..............page:961-964+993
..............page:965-971
..............page:972-976
..............page:977-982
..............page:983-985+990
..............page:986-990
..............page:991-993
..............page:994-997+1012
..............page:998-1001+1023
..............page:1002-1006
..............page:1007-1012
..............page:1013-1016
Development of JAK3 inhibitors
HU Ruo-fei;XU Yue-yang;ZHANG Er-li;WU Jun-jun;School of Chemical Engineering and Food Sciences;Hubei University of Arts and Science;Beijing Pharma Sciences Co.;Ltd.;
..............page:1017-1023
..............page:1024-1029
..............page:1030-1034+1052
..............page:1035-1040
..............page:1041-1046
..............page:1047-1052
..............page:1053-1056
..............page:1057-1060+1064
Optimized synthetic process of trelagliptin succinate
YU Jing-ping;CHEN Wu;ZHU Xue-yan;ZHANG Xi-quan;CHANG Xiao-hui;LIU Xiang-kui;State Key Lab of New Drug & Pharmaceutical Process;Shanghai Institute of Pharmaceutical Industry;Jiangsu Chia Tai Tianqing Pharmaceutical Group Co.;Ltd.;
..............page:1061-1064
..............page:1065-1068+1073
..............page:1069-1073
Analysis of the utilization of statins in six areas of China in 2013
SUN Xiu-bo;MU Lin;HE Yi-chen;DENG Li-hua;LIU Lei;Pharmaceutical Deparment of Beijing Hospital;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Science;Peking University Health Science Center;Department of Chemical Biology;School of Pharmaceutical Science;Peking University Health Science Center;
..............page:1074-1080